Cargando…

369. The DOOR is open: A Web-based Application for Analyzing the Desirability of Outcome Ranking

BACKGROUND: The Antibacterial Resistance Leadership Group (ARLG) has developed the Desirability of Outcome Ranking (DOOR) methodology, a novel paradigm for the design, conduct, analysis and interpretation of clinical trials. The DOOR methodology enables clinicians to effectively evaluate and select...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamasaki, Toshimitsu, He, Yijie, Evans, Scott R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677688/
http://dx.doi.org/10.1093/ofid/ofad500.439
_version_ 1785150189276758016
author Hamasaki, Toshimitsu
He, Yijie
Evans, Scott R
author_facet Hamasaki, Toshimitsu
He, Yijie
Evans, Scott R
author_sort Hamasaki, Toshimitsu
collection PubMed
description BACKGROUND: The Antibacterial Resistance Leadership Group (ARLG) has developed the Desirability of Outcome Ranking (DOOR) methodology, a novel paradigm for the design, conduct, analysis and interpretation of clinical trials. The DOOR methodology enables clinicians to effectively evaluate and select treatment strategies by providing an informative way to compare the patient-centered risks and benefits of intervention alternatives. There are two complementary approaches to DOOR analysis. The first approach summarizes DOOR responses between treatments by the probability of a more desirable outcome in one treatment relative to another (DOOR probability) using the concept of pairwise comparisons, The second, “partial credit” analyses, involves grading the DOOR levels on a scale from 0 (least desirable) to 100 (most desirable), allowing for strategic scoring, preferential assignment of relative importance to DOOR levels for personalized analyses, and evaluation of robustness through analysis of different scoring keys. METHODS: The Statistical and Data Management Center of the ARLG is developing interactive web-based applications (apps) with downloadable data presentations, to help clinical researchers conduct DOOR analyses. RESULTS: Two editions of the apps are available. The Standard Edition (Std) requires entry of summary level data of the DOOR outcome by intervention group. The app generates ARLG-recommended components of comprehensive DOOR analyses, including summary tables and figures of DOOR distributions, forest plot displays of DOOR probability estimates for the DOOR and its components, and partial credit analysis. The Professional Edition (Pro) reads patient-level data. In addition to the analyses provided in the Std, the Pro includes additional functionality and informed visualizations, i.e., inverse probability weighting (IPW)-based analyses, tie-breaker analyses, and the Anthology of Patient Stories plot. Data Entry Panel of the Application (Standard Edition) [Figure: see text] DOOR Frorst Plot Output (Standard Edition) [Figure: see text] DOOR Forest Plot Output from DORI-05 study of comparing IV doripenem (DOR) to IV levofloxacin (LVX), with a step-down option of oral levofloxacin in both groups after 3 days of IV therapy (Standard Edition) [Figure: see text] Partial credit analysis output from DORI-05 study of comparing IV doripenem (DOR) to IV levofloxacin (LVX), with a step-down option of oral levofloxacin in both groups after 3 days of IV therapy (Standard Edition) CONCLUSION: The DOOR apps provide comprehensive tools for researchers to implement the DOOR methodology. The apps are freely available online at https://methods.bsc.gwu.edu/. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10677688
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106776882023-11-27 369. The DOOR is open: A Web-based Application for Analyzing the Desirability of Outcome Ranking Hamasaki, Toshimitsu He, Yijie Evans, Scott R Open Forum Infect Dis Abstract BACKGROUND: The Antibacterial Resistance Leadership Group (ARLG) has developed the Desirability of Outcome Ranking (DOOR) methodology, a novel paradigm for the design, conduct, analysis and interpretation of clinical trials. The DOOR methodology enables clinicians to effectively evaluate and select treatment strategies by providing an informative way to compare the patient-centered risks and benefits of intervention alternatives. There are two complementary approaches to DOOR analysis. The first approach summarizes DOOR responses between treatments by the probability of a more desirable outcome in one treatment relative to another (DOOR probability) using the concept of pairwise comparisons, The second, “partial credit” analyses, involves grading the DOOR levels on a scale from 0 (least desirable) to 100 (most desirable), allowing for strategic scoring, preferential assignment of relative importance to DOOR levels for personalized analyses, and evaluation of robustness through analysis of different scoring keys. METHODS: The Statistical and Data Management Center of the ARLG is developing interactive web-based applications (apps) with downloadable data presentations, to help clinical researchers conduct DOOR analyses. RESULTS: Two editions of the apps are available. The Standard Edition (Std) requires entry of summary level data of the DOOR outcome by intervention group. The app generates ARLG-recommended components of comprehensive DOOR analyses, including summary tables and figures of DOOR distributions, forest plot displays of DOOR probability estimates for the DOOR and its components, and partial credit analysis. The Professional Edition (Pro) reads patient-level data. In addition to the analyses provided in the Std, the Pro includes additional functionality and informed visualizations, i.e., inverse probability weighting (IPW)-based analyses, tie-breaker analyses, and the Anthology of Patient Stories plot. Data Entry Panel of the Application (Standard Edition) [Figure: see text] DOOR Frorst Plot Output (Standard Edition) [Figure: see text] DOOR Forest Plot Output from DORI-05 study of comparing IV doripenem (DOR) to IV levofloxacin (LVX), with a step-down option of oral levofloxacin in both groups after 3 days of IV therapy (Standard Edition) [Figure: see text] Partial credit analysis output from DORI-05 study of comparing IV doripenem (DOR) to IV levofloxacin (LVX), with a step-down option of oral levofloxacin in both groups after 3 days of IV therapy (Standard Edition) CONCLUSION: The DOOR apps provide comprehensive tools for researchers to implement the DOOR methodology. The apps are freely available online at https://methods.bsc.gwu.edu/. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677688/ http://dx.doi.org/10.1093/ofid/ofad500.439 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Hamasaki, Toshimitsu
He, Yijie
Evans, Scott R
369. The DOOR is open: A Web-based Application for Analyzing the Desirability of Outcome Ranking
title 369. The DOOR is open: A Web-based Application for Analyzing the Desirability of Outcome Ranking
title_full 369. The DOOR is open: A Web-based Application for Analyzing the Desirability of Outcome Ranking
title_fullStr 369. The DOOR is open: A Web-based Application for Analyzing the Desirability of Outcome Ranking
title_full_unstemmed 369. The DOOR is open: A Web-based Application for Analyzing the Desirability of Outcome Ranking
title_short 369. The DOOR is open: A Web-based Application for Analyzing the Desirability of Outcome Ranking
title_sort 369. the door is open: a web-based application for analyzing the desirability of outcome ranking
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677688/
http://dx.doi.org/10.1093/ofid/ofad500.439
work_keys_str_mv AT hamasakitoshimitsu 369thedoorisopenawebbasedapplicationforanalyzingthedesirabilityofoutcomeranking
AT heyijie 369thedoorisopenawebbasedapplicationforanalyzingthedesirabilityofoutcomeranking
AT evansscottr 369thedoorisopenawebbasedapplicationforanalyzingthedesirabilityofoutcomeranking